PatternsRadar
Sign in

HESTERBIOHester Biosciences Limited

NSE
2,329.90INR-22.20 (-0.94%)Close · 20 Nov 2026
5 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹1,982 CrMarket cap
13.9P/E (TTM)
55.2%Delivery

Filings & corporate actions

47 results filed
CSV
Next results · Q3 FY27
Expected 30 Jan 2027 – 2 Feb 2027
Estimate: filed 30–33 days after quarter end, last 5 times
Dividend
₹11.00 per share · last 14 Jul 2026
2026
  • 5 NovresultsResults · Q2 FY27 · consolidated and standalone+4.1%NSE
  • 14 OctshareholdingShareholding · 30 Sept 2026+1.4%NSE
  • 30 JulresultsResults · Q1 FY27 · consolidated and standalone-0.7%NSE
  • 16 JulshareholdingShareholding · 30 Jun 2026+1.1%NSE
  • 14 JuldividendDividend · ₹11.00 per share-6.2%
  • 15 MayresultsResults · Q4 FY26 · consolidated and standalone-2.8%NSE
  • 20 AprshareholdingShareholding · 31 Mar 2026-0.8%NSE
  • 30 JanresultsResults · Q3 FY26 · consolidated and standalone+3.0%NSE
  • 8 JanshareholdingShareholding · 31 Dec 2025-2.2%NSE

Reaction to results · all yearsrose on day 0 in 24 of 47 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY275 Nov 2026+4.1%+0.9%—20.7×
Q1 FY2730 Jul 2026-0.7%-1.5%-8.3%8.2×
Q4 FY2615 May 2026-2.8%+3.5%+12.2%1.1×
Q3 FY2630 Jan 2026+3.0%+5.2%+8.9%4.9×
Q2 FY2612 Nov 2025+1.4%+0.7%-4.6%0.9×
Q1 FY261 Aug 2025+12.5%+0.1%+5.6%84.7×
Q4 FY259 May 2025+6.2%+12.0%+12.7%0.4×
Q3 FY2530 Jan 2025-2.4%-9.3%-25.5%4.4×
Q2 FY2528 Oct 2024+6.1%+7.8%+17.4%13.0×
Q1 FY252 Aug 2024-1.1%-13.3%-24.6%1.7×
Q4 FY2410 May 2024+4.6%+7.1%+12.2%12.0×
Q3 FY242 Feb 2024-3.9%-7.0%-7.2%3.7×
Q2 FY247 Nov 2023-3.0%-8.6%-12.4%4.2×
Q1 FY248 Aug 2023+3.7%0.0%+3.1%22.7×
Q4 FY2317 May 2023-6.0%-10.7%-10.5%7.4×
Q3 FY2331 Jan 2023+5.8%+3.7%+0.1%19.1×
Q2 FY237 Nov 2022+0.4%-1.9%-5.9%1.4×
Q1 FY2310 Aug 2022-6.3%-13.6%-12.2%12.2×
Q4 FY2223 May 2022-1.5%-1.7%-4.7%0.4×
Q3 FY2231 Jan 2022+4.7%+2.6%-8.2%10.2×
Q2 FY2228 Oct 2021+0.2%+2.0%-8.1%1.3×
Q1 FY2212 Aug 2021+9.7%+6.6%+16.4%33.3×
Q4 FY218 Jun 2021-2.3%-5.4%-7.3%0.4×
Q3 FY2130 Jan 2021+4.3%+3.8%+2.7%1.4×
Q2 FY211 Nov 2020-2.4%-0.6%+1.7%0.8×
Q1 FY2130 Jul 2020-0.1%+7.5%+12.4%0.6×
Q4 FY2026 Jun 2020-3.7%-3.4%+1.8%1.5×
Q3 FY207 Feb 2020-3.8%-7.7%-15.9%2.8×
Q2 FY206 Nov 2019+1.7%-4.2%-4.9%6.4×
Q1 FY2031 Jul 2019-1.3%+5.7%+5.2%4.4×
Q4 FY199 May 2019-0.1%-3.7%+19.6%0.5×
Q3 FY1930 Jan 2019+2.7%+16.0%+7.6%1.8×
Q2 FY1930 Oct 2018-1.1%-1.0%+1.6%0.1×
Q1 FY1924 Aug 2018-1.2%-1.9%-13.6%1.7×
Q4 FY1818 Jun 2018+0.6%+2.7%-4.2%0.4×
Q3 FY1823 Jan 2018-3.5%-6.9%-5.5%0.8×
Q2 FY1810 Nov 2017-3.6%-1.5%+24.4%1.1×
Q1 FY181 Aug 2017+0.3%-7.1%-14.2%0.1×
Q4 FY1716 Jun 2017+0.3%-3.2%+18.4%0.5×
Q3 FY1719 Jan 2017+0.1%+1.1%+0.4%2.3×
Q2 FY1720 Oct 2016-0.8%-0.4%-5.9%21.8×
Q1 FY177 Sept 2016+1.2%+0.5%-3.8%1.7×
Q4 FY169 May 2016+20.0%+15.5%+17.5%18.5×
Q3 FY1614 Feb 2016+10.6%+9.7%+19.2%0.7×
Q2 FY1629 Oct 2015-3.1%-6.4%-1.2%0.4×
Q1 FY1622 Jul 2015+0.9%-2.9%-7.5%1.8×
Q4 FY1528 May 2015-1.2%+3.0%+13.8%3.5×
Average+1.0%-0.1%+0.4%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+38.0%
Profit YoY+40.9%
Interest cost YoY+122.9%
Revenue QoQ+26.8%
Profit QoQ-79.0%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+6.3%+5.5%—+7.7%+11.1%—
Profit+146.1%+76.9%—+25.8%+32.2%—

Key data

Open2,352.10
Day range2,306.40 – 2,419.40
52-week range1,239.30 – 2,683.60
From 52w high-13.2%
RSI (14)55.2
ATR (14)95.10
Volume5.1K
Avg volume (20D)5.5K
Rel volume0.91×
Volatility (1Y)42.3%
Turnover₹1.2Cr
Traded value (NSE)₹1.2Cr
VWAP2,356.83
SMA 50 / 2002,226.83 / 1,981.65
Price band20%

Delivery percentage

Latest · 20 Nov 202655.2%
20-day avg54.0%
1-year avg56.0%
Percentile (own history)31st
Range4.0–100.0%
Sessions2,876

Over the last 20 sessions HESTERBIO settled 54.0% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 56.0%. The latest session ranks higher than 31% of the 2,876 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.47%
Dividend, trailing 12M₹11.00
Paid every year for10+ yr
Shareholders11.7K · -2.3% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buynever

Performance returns

1D1W1M3M6M1Y
Price-0.94%+0.27%+8.53%-3.45%+23.81%+38.69%

Valuation

Market cap₹1,982 Cr
Market cap (NSE)₹1,982 Cr
Free-float cap₹1,104 Cr
P/E (TTM)13.9
P/E (NSE)14.0
EPS (TTM)167.03
P/B4.2
Net margin (TTM)40.3%
Other income / PBT0.5%
ROE35.3%
Debt / equity0.21
Shares outstanding85.07L
Listed13 Mar 2015

Ownership

Promoter44.28%
Promoter Δ QoQ-9.45 pp
Public55.72%
FII0.31%
DII0.08%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)77.4100.177.297.9
YoY chg+22.5%+22.2%-8.2%+38.0%
Net profit (₹ Cr)9.316.596.720.6
YoY chg-18.4%+973.7%+459.3%+44.0%
Net margin12.0%16.5%125.2%21.1%
EPS10.9419.45113.7123.94

Shareholding over time

By quarter

30 Sept 2026 · promoter 44.28% · public 55.72%
30 Sept 2021: promoter 53.73%31 Dec 2021: promoter 53.73%31 Mar 2022: promoter 53.73%30 Jun 2022: promoter 53.73%30 Sept 2022: promoter 53.73%31 Dec 2022: promoter 53.73%31 Mar 2023: promoter 53.73%30 Jun 2023: promoter 53.73%30 Sept 2023: promoter 53.73%31 Dec 2023: promoter 53.73%31 Mar 2024: promoter 53.73%30 Jun 2024: promoter 53.73%30 Sept 2024: promoter 53.73%31 Dec 2024: promoter 53.73%31 Mar 2025: promoter 53.73%30 Jun 2025: promoter 53.73%30 Sept 2025: promoter 53.73%31 Dec 2025: promoter 53.73%31 Mar 2026: promoter 53.73%30 Jun 2026: promoter 53.73%30 Sept 2026: promoter 44.28%
2021-092026-09
  • Promoter
  • Public and others
Promoter
44.28%
Public
55.72%
Promoter change
-9.45 pp
Filed
14 Oct 2026
FII
0.31%
DII
0.08%
Promoter pledged
0.00%

Who the public is

Mutual funds
0.00%

0.00 pp QoQ

Insurance
0.00%

0.00 pp QoQ

FPI
0.30%

-0.01 pp QoQ

Retail ≤ ₹2L
17.72%

-0.70 pp QoQ

HNI > ₹2L
14.98%

+0.40 pp QoQ

NRI
15.43%

+10.03 pp QoQ

Bodies corporate
3.40%

+0.69 pp QoQ

Shareholders
11,685

-2.3% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
Rajiv Dinesh GandhiPromoter · Individual10.48%
Sanjiv Dinesh GandhiPromoter · Individual8.20%
Nina Rajiv GandhiPromoter · Individual8.19%
Shaila Bhupendra GandhiPromoter · Individual5.78%
Ravin GandhiIndividual4.74%
Bela GandhiIndividual4.71%
Bhupendra Vithaldas GandhiPromoter · Individual4.68%
Kuntal Hasmukhlal ShahIndividual3.17%
Biolink Healthcare LimitedPromoter · Corporate2.93%
Manish JainIndividual2.88%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 10 Sept 2015 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹11.00₹11.00
FY2025-261₹7.00₹7.00
FY2024-251₹6.00₹6.00
FY2023-241₹8.00₹8.00
FY2022-231₹10.00₹10.00
FY2021-221₹10.00₹10.00
FY2020-211₹6.60₹6.60
FY2019-201₹7.00₹7.00
FY2018-193₹10.00₹10.00
FY2017-182₹6.30₹6.30
FY2016-172₹4.10₹4.10
FY2015-162₹6.10₹6.10
Ex-dateRecord dateDeclaredAdjusted
14 Jul 2026—₹11.00₹11.00
6 Aug 2025—₹7.00₹7.00
22 Aug 2024—₹6.00₹6.00
13 Sept 2023—₹8.00₹8.00
11 Aug 2022—₹10.00₹10.00
5 Aug 2021—₹10.00₹10.00
27 Aug 2020—₹6.60₹6.60
18 Jul 2019—₹7.00₹7.00
9 Nov 2018—₹2.00₹2.00
30 Aug 2018—₹2.00₹2.00
2 Aug 2018—₹6.00₹6.00
16 Nov 2017—₹4.00₹4.00
20 Jul 2017—₹2.30₹2.30
3 Nov 2016—₹3.00₹3.00
21 Jul 2016—₹1.10₹1.10
17 Mar 2016—₹3.00₹3.00
10 Sept 2015—₹3.10₹3.10

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
6.7 years ago
Disclosures on record
35
19 open-market of the newest 35
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
19 Mar 2020Shaila Bhupendra GandhiPromoterBuy145₹2.1L1,432.471.90L → 1.90L2.23%+0.00 pp7(2)told 17 Mar 2020
19 Mar 2020Bhupendra Vittaldas Gandhi HUFPromoterBuy5₹6,8291,365.803.12L → 3.12L3.66%+0.00 pp7(2)told 17 Mar 2020
19 Mar 2020Bhupendra Vittaldas GandhiPromoterBuy18₹24,7501,375.003.99L → 3.99L4.69%+0.00 pp7(2)told 17 Mar 2020
11 Dec 2019YASH RAJIV GANDHIPromoterBuy100₹1.6L1,580.843.1K → 3.3K0.04%+0.00 pp7(2)told 11 Dec 2019
1 Oct 2019Madhuri KapadiaPromoterSell903₹15.9L1,763.802.06L → 2.05L2.41%-0.01 pp7(2)told 30 Sept 2019
27 Sept 2019Madhuri KapadiaPromoterSell29.8K₹5.6Cr1,861.332.36L → 2.06L2.43%-0.35 pp7(2)told 27 Sept 2019
14 Sept 2018BHAVNA JIGAR SHAHRelativeBuy106₹1.3L1,224.79744 → 8500.01%+0.00 pp7(2)told 14 Sept 2018
7 Sept 2018BHAVNA JIGAR SHAHRelativeBuy112₹1.4L1,245.39632 → 7440.01%+0.00 pp7(2)told 7 Sept 2018
31 Aug 2018BHAVNA JIGAR SHAHRelativeBuy100₹1.3L1,251.50532 → 6320.01%+0.00 pp7(2)told 31 Aug 2018
12 Jun 2018YASH RAJIV GANDHIPromoterBuy300₹3.8L1,274.802.9K → 3.1K0.04%+0.00 pp7(2)told 12 Jun 2018
14 Mar 2018BHAVNA JIGAR SHAHRelativeBuy72₹1.2L1,622.88460 → 5320.01%+0.00 pp7(2)told 14 Mar 2018
10 Mar 2018BHAVNA JIGAR SHAHRelativeBuy200₹3.3L1,630.31260 → 4600.01%+0.00 pp7(2)told 10 Mar 2018
7 Mar 2018BHAVNA JIGAR SHAHRelativeBuy260₹4.3L1,665.05— → 2600.00%7(2)told 7 Mar 2018
8 Feb 2018YASH RAJIV GANDHIPromoterBuy300₹4.5L1,488.312.5K → 2.9K0.03%+0.00 pp7(2)told 8 Feb 2018
6 Feb 2018JIGAR PRAVINCHANDRA SHAHKMPBuy100₹1.4L1,444.991.1K → 1.2K0.01%+0.00 pp7(2)told 6 Feb 2018
16 Aug 2017YASH RAJIV GANDHIPromoterBuy750₹6.8L904.941.8K → 2.5K0.03%+0.01 pp7(2)told 16 Aug 2017
24 Mar 2017Hester Coatings LLPPromoterSell90.0K~₹6.6Cr728.6090.0K → —0.00%7(2)told 24 Mar 2017
24 Mar 2017Rajiv GandhiPromoterBuy90.0K~₹6.6Cr728.608.59L → 9.49L11.16%+1.06 pp7(2)told 24 Mar 2017
20 Jul 2016YASH GANDHIPromoterBuy700₹5.1L723.181.1K → 1.8K0.02%+0.01 pp7(2)told 19 Jul 2016

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to HESTERBIO.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations67.079.382.383.763.281.984.171.077.4100.177.297.9
Other income1.04.11.21.87.8(7.0)2.39.70.7(3.0)1.61.5
Total income68.083.483.585.571.075.086.480.778.197.178.999.4
Total expenses62.874.073.874.658.672.567.365.865.976.864.675.3
└ Finance costs2.26.95.05.9(3.8)5.61.82.21.85.13.13.0
└ Depreciation3.73.74.14.24.34.24.24.44.45.97.07.1
Profit before tax5.29.49.710.912.42.419.114.912.223.299.624.6
Tax expense2.43.53.13.52.02.22.92.74.28.55.05.8
Net profit4.06.47.58.411.41.517.314.39.316.596.720.6
EPS4.737.528.809.8613.411.8220.3316.8510.9419.45113.7123.94
Net margin6.00%8.07%9.10%10.03%18.05%1.88%20.56%20.19%12.03%16.53%125.23%21.07%
PBT margin7.77%11.84%11.83%13.04%19.60%2.97%22.75%20.97%15.77%23.21%129.00%25.07%
Tax rate45.95%36.99%31.92%31.86%15.80%90.51%15.11%18.17%34.52%36.77%4.97%23.72%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 5 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets670.0683.0662.3669.3653.4675.2677.9683.3
Current assets227.6238.3214.6222.2195.2203.7208.6221.8
└ Cash & equivalents13.213.012.713.65.66.32.823.5
└ Other bank balances1.71.42.63.21.61.63.83.7
└ Current investments0.00.00.00.00.00.00.00.0
└ Trade receivables79.698.978.694.173.292.695.481.7
└ Inventories84.880.475.667.270.465.972.578.9
Total equity288.5291.5302.9314.2326.7351.0367.8475.3
└ Attributable to owners279.7281.9291.8301.8314.3337.9360.2467.8
└ Non-controlling interest8.89.611.112.412.413.17.67.6
└ Share capital8.58.58.58.58.58.58.58.5
Borrowings268.2267.3239.0239.1207.8207.6188.3102.1
└ Current83.377.057.384.174.494.198.358.8
└ Non-current184.9190.3181.8155.0133.4113.690.043.4
Trade payables30.030.026.424.729.428.524.722.9
Current liabilities148.7131.7105.8126.8125.2141.4152.598.9
Total liabilities381.4391.5359.5355.0326.7324.1310.2207.9
Net debt253.3252.8223.7222.3200.6199.7181.774.9
Debt / equity0.930.920.790.760.640.590.510.21
Current ratio1.531.812.031.751.561.441.372.24

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow23.65.748.124.164.517.564.149.0
└ Capex(77.8)(13.9)(24.4)(13.0)(20.6)(8.4)(17.8)(4.2)
Free cash flow(54.2)(8.3)23.711.143.99.146.344.8
Investing cash flow(77.0)(13.7)(22.7)(13.0)(19.0)(2.3)(3.3)(2.8)
Financing cash flow41.89.0(26.0)(10.1)(51.7)(15.6)(48.8)(24.4)
└ Dividends paid(8.5)(6.8)(6.8)(5.1)(5.2)(6.0)(6.0)(9.3)
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash(11.6)1.0(0.6)1.0(6.2)(0.4)12.120.8

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

HESTERBIO at a glance

  • HESTERBIO closed at ₹2,329.9 on 20 Nov 2026, -0.94% on the day, +38.7% over one year, 13.2% below its 52-week high of ₹2,683.6.
  • Delivery was 55.2% of traded quantity on 20 Nov 2026, the 31st percentile of its own 2,876 sessions with a reading (20-session average 54.0%, 1-year average 56.0%).
  • Market capitalisation is ₹1,982 crore at a trailing P/E of 13.9 (trailing EPS ₹167.03).
  • Q2 FY27 results (consolidated, filed 5 Nov 2026): revenue ₹98 crore (+38.0% year on year), net profit ₹21 crore (+44.0%); the price moved +4.1% on the first session after.
  • Promoters held 44.28% at 30 Sept 2026, down 9.45 percentage points on the previous filing.
  • Q3 FY27 results are expected between 30 Jan 2027 and 2 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE782E01017
SeriesEQ
Listed13 Mar 2015
NSE market cap · 17 Nov 2026₹1,978 Cr
Free-float market cap (NSE)₹895 Cr
Shares outstanding (NSE)85.07L
History from13 Mar 2015
Sessions2,893

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.